A neoteric breakthrough in Precision Medicine has been acclaimed as the steppingstone in disease prediction and prevention strategies. This integral change in our approach to medication therapy has federal efforts in developing the ‘’Hyperindividualised’’ therapy while taking into account the genetic patterns, drug responses, lifestyle and cultural environment. The substantial research in disease treatment strategies have contributed to developing target drugs, study of novel biomarkers in disease diagnosis, regenerative medicine leading to customized therapeutic approaches. Precision Medicine will not only have an impact on targeted treatment delivery but the prospect of studying the biological complexity of disorders associated with high mortality rate and cost-efficient treatment plans.

MarketsandMarkets is delighted to announce its Precision Medicine Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. The conference will assimilate diverse sessions on Comprehensive Overview of Precision Medicine, Novel horizons in biomarker strategies, Current Multi Omics analysis, Artificial Intelligence and Machine Learning, Gene expression Profiling in Precision Medicine, Contributions of Tissue engineering and Regenerative Medicine in target drug discovery. The event encompasses networking sessions, panel discussions, solutions, and services catering to precision medicine. The conference will constellate a full spectrum of experts, leaders, and stakeholders to share a board prospective the novel research and development in Precision Medicine. 

Read on events.marketsandmarkets.com

International Conference on Population Health Management and Patient Engagement aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results on all aspects of Population Health Management and Patient Engagement. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Population Health Management and Patient Engagement.

Read on waset.org

The program format will provide timely data from the latest clinical trials and updates on state-of-the-art techniques through lectures, case presentations, and interactive discussions. Join your colleagues for the latest updates and practice guidelines in cardiology.

Topics to be Discussed:
Heart Failure
Valvular Heart Disease
Cardiac Arrhythmias
Ischemic Heart Disease
Adult Congenital Heart Disease
Prevention

LEARNING OBJECTIVES

-Describe the latest diagnostic and management strategies in heart failure
-Cite best practices for the management of patients with atrial fibrillation and ventricular arrhythmias
-Summarize the newer concepts of management of heart failure, cardiomyopathies, and valvular disease
-Identify recommendations for lipid and hypertension management

INTENDED AUDIENCE
This course is intended for clinical cardiologists, cardiac surgeons, family practice, general internists, physician assistants, nurse practitioners, and allied health personnel with a cardiovascular interest; however, pediatric cardiologists, radiologists, and other medical specialists will find the presentations and panel discussions valuable.

Time: 07:30 to 23:00

The Canadian Health and Wellbeing in Developmental Disabilities Conference is an interprofessional conference where health care providers and community partners connect to share educational and informative updates and practical, innovative, promising and effective practices that improve the health and wellbeing of people with developmental disabilities across the lifespan. The conference strives to achieve equity, diversity, and inclusion through recognition of intersectionality the inter-connected nature of social categorizations such as race, class, and gender as they apply to people with developmental disabilities, creating overlapping and interdependent systems of discrimination or disadvantage.

Read on healthandwellbeingindd.ca

The ASSR is a subspecialty society under the auspices of the American Society of Neuroradiology (ASNR) focusing on spine imaging and image-guide interventions. Originally founded in May 1993, the ASSR has grown to over 600 active US and international members from diverse clinical and scientific backgrounds dedicated to advanced the field of spinal disease diagnosis and therapy.

Read on theassr.org

Join us in February 2023, as SAE Media Group's 6th annual 3D Cell Culture Conference brings together industry experts from big pharma, regulatory bodies, and cutting-edge researchers to discuss the challenges and drivers of these medical technologies, through case studies of the latest innovations in 3D Cell Culture models, real world examples of clinical applications, and insights into regulatory validation and high throughput screening to give a comprehensive look into this fast growing industry. 3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to reach a value of $3.48 Billion by 2028. The pharmaceutical industry globally is realising the growing potential of in vitro tissue models for drug discovery, pathology modelling and validation, safety and toxicity. 3D Cell Culture technology promises to offer increased translatability in models and reduce the costly rates of drug attrition in the discovery process -- heralding the next major advance in the discovery of pharmaceuticals. [Read on smgconferences.com](https://www.smgconferences.com/pharmaceuticals/uk/3D-Cell-Culture?utm_medium=www.3d-cellculture.com&utm_source=P-392&utm_campaign=Evvnt#tab_overview)

RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious, and chronic diseases. This is reflected with the value of the global antisense and RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%. With Covid-19 rapidly accelerating the RNA landscape through massive regulatory successes, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, there has been considerable progress in the development of RNA medicines and a major expansion of the RNA-therapeutics field.

In 2023 we will see the return of SAE's RNA Therapeutics conference to a live in-person event, showcasing an update on mRNA therapeutic applications, coupled with an industry outlook of the field. We will also explore the latest trends in novel RNA therapies, including developments in AI modelling and small molecule modulation of RNA. Further topics to be examined comprise of novel RNA modalities encompassing self-amplifying RNA, saRNA, circular RNA, lnc RNA and many more.

Don't miss this unmissable opportunity to network with the pharma and biotech community of global experts in the UK and Europe; the two-day agenda offers you peer-to-peer networking with Directors of novel RNA therapies, CEOs, Senior and expert scientists, Chief Medical Officers, Senior Vice Presidents and many more.

Benefits of attending:
- Explore how mRNA leads the way in the genetic medicine space as the next generation of novel drug modalities
- Investigate the latest trends in AI drug discovery as a tool for designing novel RNA based therapeutics
- Enhance your knowledge of the latest innovations in RNA application and RNA delivery techniques with case studies from BioNTech, Neuway Pharma and Ethris GmbH
- Engage in the growing advances and development of novel RNA molecules in the treatment of chronic respiratory, neurodegenerative, and infectious diseases

Who should attend:
- Directors of novel RNA therapies
- CEOs
- Senior and expert scientists
- Chief Medical Officers
- Chief Technical Officers
- Senior Vice Presidents
- Global Heads of mRNA R and D
- Global Medical Directors
- Heads of Translational Medicine
- Director, Clinical Pharmacology
- Global Head of RNA and Targeted Therapeutics
- Clinical Science Director
- Head of Biology
- Director, Genetic Medicine
- Associate Director

Read on go.evvnt.com

MD&M West brings together medtech engineers, business leaders, disruptive companies, and innovative thinkers to create powerful solutions and life-changing medical devices. DISCOVER medical design and manufacturing innovations and technology. Discover and demo the latest products, technology, and solutions from more than 1,400 suppliers. Explore the other four engineering trade shows that share the expo floor with MD&M West. From packaging to plastics to robotics, our five-in-one design and manufacturing event connects you across multiple verticals and industries.

Read on mdmwest.com

More and more, healthcare organizations are modernizing their IT infrastructure and applications. Navigating this complex transformation creates considerable challenges for health system technology leaders. In this session, Norfolk, Va.-based Sentara Healthcare CTO Jeffrey Thomas will demystify digital transformation and share innovative practices that helped his health system transition to a multi-cloud infrastructure with ease, flexibility, scale and security. 

Learning objectives include: 

• Architecting and building a dynamic infrastructure in local cloud and near-cloud environments
• Understanding technology's upstream impacts to healthcare business outcomes
• Planning and managing the organizational change required to support digital transformation in healthcare

Read on go.beckershospitalreview.com

As sensors are continuously becoming smaller and cheaper, there’s a great opportunity to generate vast amounts of data for improving our health. Through the use of artificial intelligence we can more efficiently search for that needle in the haystack of zettabytes of data; that one combination that leads to the results we want. This opens the door to personalized treatments where – based on your individual data – your personal solution is presented. In this talk, we’ll explain how we’re building towards this vision at imec in a combination of software and hardware efforts.

Read on opendigitalhealth.org